• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Kamala Harris should prosecute Big Pharma, not bail it out

by October 7, 2024
written by October 7, 2024

With less than six weeks before the election, Vice President Kamala Harris has been striking a populist tone, especially when it comes to taking on Big Pharma in her stump speeches. At a recent campaign rally, she touted her tie-breaking vote to pass the Inflation Reduction Act, which granted Medicare the ability ‘to go toe-to-toe with Big Pharma and negotiate lower drug prices.’ 

And to great fanfare, just before the Democratic National Convention, the White House announced that the first round of those drug price negotiations would save taxpayers a cool $6 billion – a major win for the American taxpayer.  

Yet at this very moment, the Biden-Harris administration is quietly pushing for a multi-billion-dollar bailout of one of the nation’s largest and wealthiest drug companies – a bailout that would be funded by those same taxpayers.  

The proposed bailout revolves around a patent infringement lawsuit. Arbutus and Genevant Sciences, two small biotech companies, allege that Moderna stole their patented lipid nanoparticle technology, which proved critical in developing Moderna’s mRNA vaccine for COVID-19. 

Though the case is yet to be decided, the U.S. Patent and Trademark Office and Federal Circuit Court of Appeals have already determined Arbutus’ patents to be valid, despite Moderna’s attempt to invalidate the patents before the pandemic. Given the stakes of this case, court-ordered damages could reach $3 billion, according to some analysts. 

While this may appear to many as an obscure issue of corporations battling it out over patent infringement, there are serious ramifications for taxpayers here as well.  

In a rare statement of interest filing, Department of Justice officials recently argued that due to an obscure federal law dating back to World War I, Moderna is excused from any patent infringement that may have occurred during Operation Warp Speed, the historic federal campaign to support COVID-19 vaccine development. If that’s the case, the lion’s share of the financial penalty for Moderna’s potential wrongdoing will fall on U.S. taxpayers.  

The law, known as Section 1498, essentially states that the government will compensate an inventor for patent infringement if the technology in question is ‘used or manufactured by or for the United States.’  

In times of great national need, the government may decide they need niche technology at a scale that the original patent-holding manufacturer can’t provide. The law absolves the larger manufacturer from having to worry about licensing the patent from the original patent-holder or deal with the patent-holder taking them to court for infringement. 

Put more simply, Section 1498 is similar to eminent domain, but rather than letting the government seize private land, it allows the government to seize patented inventions in emergencies and retroactively compensate the patent holders. 

Here’s where the DOJ’s argument falls short, as Moderna’s infringement clearly should not be covered by Section 1498. The government never asked them to infringe on the intellectual property of anyone else and never authorized widespread production of Moderna’s COVID-19 vaccine by other companies due to manufacturing capacity issues.  

And critically, the vaccines in question weren’t used exclusively or even primarily by the U.S. government – meaning military service members or other federal employees – but were instead distributed to regular Americans like you and me.  

Yet at this very moment, the Biden-Harris administration is quietly pushing for a multi-billion-dollar bailout of one of the nation’s largest and wealthiest drug companies – a bailout that would be funded by those same taxpayers.  

‘By or for’ government use has always been understood to mean that the U.S. government is the end user of the product in question – for instance, a patented technology that’s appropriated for U.S. military use – not that it’s merely a purchaser. Objectively, the U.S. government was merely one buyer among many purchasers of the vaccines – including many foreign governments and other foreign state-owned companies.  

If the court overseeing the case accepts the DOJ’s interpretation of Section 1498, it will set a precedent that companies that merely sell to the government, among other customers, are immune from patent infringement lawsuits. That result would be disastrous for our economy and a boon to wrongdoers. 

Patents encourage innovation and risk-taking by enabling anyone with a novel idea to turn it into a real-world product – without bigger, entrenched rivals stealing it. Allowing huge corporations to essentially steal patented technology from small upstarts is the opposite of standing up for the little guy. It’d greatly disincentivize investments in research and development. 

Harris has a strong history of standing up for the ‘little guy’ going back to her early years as a prosecutor and San Francisco District attorney. The vice president should continue that legacy and make clear that in a Harris administration, large corporations will be held accountable if found responsible – a winning message in the final campaign stretch.  

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Saving lives on ‘Death Street,’ how an Israeli kindergarten teacher became a battlefield hero on October 7
next post
Women for Trump, Goya team up to provide relief to Hurricane Helene victims in Georgia

related articles

Examining the next threat from Communist China: Our...

October 23, 2025

Sparks fly as Cuomo, Mamdani tear into each...

October 23, 2025

Trump meets NATO’s Rutte amid canceled Putin meeting:...

October 22, 2025

Schumer blocks 12th GOP bid to reopen government...

October 22, 2025

FLASHBACK: Ted Cruz predicts ballooning Obamacare subsidies now...

October 22, 2025

DAVID MARCUS: 5 things New York Republicans need...

October 22, 2025

American missionary kidnapped in Niger by suspected Islamist...

October 22, 2025

Jack Smith defends subpoenaing Republican senators’ phone records:...

October 22, 2025

Trump meets NATO’s Rutte as Ukraine peace talks...

October 22, 2025

Trump suggests DOJ owes him money for past...

October 22, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Trump plans to have annual physical exam later this week: ‘Never felt better’

    April 8, 2025
  • Pelosi addresses whether there’s ‘way back’ to Biden friendship after Dem pressure campaign to drop out

    August 11, 2024
  • President-elect Trump announces Pam Bondi as his new pick for US attorney general

    November 22, 2024
  • Dem senator accuses top Trump official of being responsible for ‘hundreds of thousands of children dying’

    June 26, 2025
  • From Zapruder to smartphones: Assassination footage reshapes America’s view of political violence

    September 14, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 4

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (6,497)
  • Investing (634)
  • Stock (941)

Latest Posts

  • Thune slams Democrats’ ‘cold-blooded partisan’ tactics as funding deadline nears

    September 22, 2025
  • What makes iDEGEN an exciting meme coin to buy as we head into 2025?

    December 27, 2024
  • COUNTDOWN: Harris has just 4 days left to make good on sit-down interview proclamation

    August 27, 2024

Recent Posts

  • Canadian politician claims Trump admin’s ’51st state’ rhetoric is an ‘act of war’

    March 21, 2025
  • Elon Musk opines on ‘major driver of white males becoming trans’

    September 3, 2025
  • House GOP leaders scramble for Plan B after Trump, Musk lead conservative fury against spending bill

    December 19, 2024

Editor’s Pick

  • USAID reportedly bankrolled al Qaeda terrorist’s college tuition, unearthed records show

    February 10, 2025
  • 100 days of injunctions, trials and ‘Teflon Don’: Trump second term meets its biggest tests in court

    April 29, 2025
  • Mar-a-Lago trumps White House as president-elect overshadows Biden on world stage

    December 3, 2024
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock